GeneDx Holdings Corp. (WGS) reported earnings of $0.50 per share for the quarter ended June 2025, surpassing the Zacks Consensus Estimate of $0.10 and showing an improvement from a loss of $0.11 per share a year ago. The company also achieved revenues of $102.69 million, exceeding estimates by 21.24% and up from $70.51 million year-over-year.
The earnings surprise of +400.00% marks the fourth consecutive quarter where GeneDx outperformed consensus EPS estimates. The firm’s stocks have risen approximately 10.5% year-to-date, compared to the S&P 500’s 8.6% increase. Analysts project a consensus EPS of $0.30 and revenues of $93.15 million for the next quarter.
